APOE and Alzheimer disease: However, there were no differences in the SUVR between SSRI+ and SSRI− ApoE4 carriers regardless of the diagnosis (Mann–Whitney U test; AD: p = 0.7909; MCI: p = 0.3644; cognitively normal: p = 0.9065; Figure 6).